Clinical Trials Browser

Phase 1/2 × Recruiting × HER2-positive Gastric Cancer × Clear all

NCT06572319 2024-08-27

Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens

Phase 1/2 Recruiting

Gastrointestinal

HER2-positive Gastric Cancer